About Noida International University
Noida International University was established in the year 2010 by an Act (Act No. 27 of 2010) of the Uttar Pradesh State Legislature. The University is approved under Section 2(f) & 12(b) of UGC Act 1956 and empowered to award degrees as specified by UGC under section 22 of UGC Act 1956. The University is accredited by National Assessment and Accreditation Council (NAAC) with A+ grade, a score of 3.44 highest among private universities in cycle 1 and is also a member of Association of Indian Universities (AIU).
The University has received prestigious recognition by the Department of Science and Industrial Research (DSIR) under the scheme on Recognition of Scientific and Industrial Research Organizations (SIROs), as a Scientific and Industrial Research Organization (SIRO) in 2022 and 2025.
About the School of Pharmacy (SOP)
The School of Pharmacy, Noida International University (NIU) is committed to excellence in pharmaceutical education, research, innovation, and professional practice. Approved by the Pharmacy Council of India (PCI), the school offers industry-oriented academic programmes designed to prepare competent pharmacists, researchers, and healthcare professionals capable of addressing contemporary challenges in pharmaceutical sciences and global healthcare.
With a strong emphasis on experiential learning, the school integrates classroom instruction with extensive laboratory training, industrial exposure, research projects, and clinical perspectives.
Students gain comprehensive knowledge across diverse domains, including pharmaceutics, pharmaceutical chemistry, pharmacology, pharmacognosy, pharmaceutical analysis, pharmacy practice, and biotechnology, supported by modern laboratories equipped with advanced instrumentation and experienced faculty members.
The school actively promotes interdisciplinary research in emerging areas such as artificial intelligence in drug discovery, computational pharmaceutics, nanotechnology, advanced drug delivery systems, precision medicine, pharmaceutical biotechnology, digital therapeutics, regulatory sciences, and sustainable pharmaceutical manufacturing. Through collaborations with pharmaceutical industries, healthcare organizations, and research institutions, students are encouraged to participate in internships, industrial visits, conferences, workshops, innovation challenges, and research publications, fostering both academic excellence and professional development.
Committed to the vision of “Transforming Healthcare through Innovation and Research,” the school nurtures ethical values, scientific inquiry, entrepreneurship, and lifelong learning. Its curriculum is aligned with evolving national and global healthcare needs, ensuring graduates are well prepared for careers in pharmaceutical industries, research and development, regulatory affairs, quality assurance, clinical research, hospital pharmacy, academia, and public health.
As part of Noida International University, a multidisciplinary institution with a vibrant international academic environment, the School of Pharmacy provides an ideal ecosystem for collaborative research and innovation. By integrating digital technologies, Industry 5.0 principles, and sustainable healthcare practices, it continues to contribute significantly to pharmaceutical education, translational research, and the advancement of global healthcare.
About the Conference
Pharmaceutical Sciences in the Digital Era: Fostering Innovation, Multidisciplinary Research and Sustainable Global Healthcare 2026 (ICPSDE-2026) is a two-day international conference organized by the School of Pharmacy, Noida International University, on 20–21 November 2026. The conference brings together researchers, academicians, healthcare professionals, pharmaceutical scientists, industry experts, regulatory authorities, and students to explore emerging technologies and innovative approaches that are transforming pharmaceutical sciences and global healthcare.
Covering a broad spectrum of contemporary research areas, including artificial intelligence, digital health, pharmaceutical biotechnology, nanotechnology, computational drug discovery, precision medicine, advanced drug delivery systems, clinical pharmacy, regulatory sciences, herbal medicines, and sustainable pharmaceutical manufacturing, the conference provides a multidisciplinary platform for the exchange of scientific knowledge and technological innovation. It aims to foster collaborative research that bridges pharmaceutical sciences with engineering, life sciences, biomedical sciences, information technology, and healthcare to address current and future global health challenges.
The conference seeks to promote research, innovation, and technological advancement across pharmaceutical sciences by encouraging collaboration among academicians, researchers, clinicians, industry professionals, policymakers, and scholars from India and abroad. It provides an opportunity to present cutting-edge research, discuss emerging trends, and share best practices that contribute to the development of safer, smarter, and more sustainable healthcare solutions. The scientific programme will feature keynote lectures, invited talks, technical sessions, poster presentations, and panel discussions led by internationally recognized experts from academia, research organizations, healthcare institutions, and the pharmaceutical industry.
Aligned with the principles of Industry 5.0, digital transformation, and the United Nations Sustainable Development Goals (SDGs), the conference emphasizes human-centric innovation, intelligent healthcare technologies, sustainable pharmaceutical development, and translational research that supports resilient healthcare systems. By fostering interdisciplinary collaboration and international partnerships, the conference aims to accelerate the adoption of digital technologies that enhance drug discovery, pharmaceutical manufacturing, healthcare delivery, and patient outcomes.
Objectives of the Conference
The International Conference on Pharmaceutical Sciences in the Digital Era: Fostering Innovation, Multidisciplinary Research and Sustainable Global Healthcare 2026 (ICPSDE-2026) aims to:
Provide a global platform for researchers, academicians, healthcare professionals, industry experts, and students to exchange knowledge, present innovative research, and discuss recent advances in pharmaceutical sciences and digital healthcare.
Promote multidisciplinary research and collaboration by integrating pharmaceutical sciences with artificial intelligence, biotechnology, biomedical engineering, data science, computational sciences, and other emerging technologies.
Encourage innovation in pharmaceutical research through advancements in drug discovery, drug delivery systems, nanomedicine, precision medicine, pharmaceutical biotechnology, digital therapeutics, and sustainable pharmaceutical manufacturing.
Strengthen academia–industry–healthcare partnerships to facilitate knowledge transfer, translational research, technology commercialization, entrepreneurship, and the development of patient-centric healthcare solutions.
Showcase emerging technologies and best practices in pharmaceutical research, clinical pharmacy, regulatory sciences, quality assurance, digital health, and intelligent healthcare systems that improve healthcare delivery and patient outcomes.
Support early-career researchers and young scientists by providing opportunities to present research findings, receive expert feedback, build professional networks, and establish national and international collaborations.
Advance sustainable and future-ready healthcare by fostering scientific excellence and innovation aligned with Industry 5.0, digital transformation, responsible research practices, and the United Nations Sustainable Development Goals (SDGs).
Who Should Attend?
Academicians, Researchers, and Scientists
Undergraduate, Postgraduate, and Ph.D. Scholars
Pharmaceutical, Biotechnology, and Healthcare Professionals
Industry Experts, Innovators, and Entrepreneurs
AI, Digital Health, and Computational Science Professionals
International Delegates and Collaborators
Why Should You Attend?
Learn from renowned international speakers and industry experts.
Present your research and receive valuable expert feedback.
Network with leading academicians, researchers, and professionals.
Explore the latest innovations in pharmaceutical sciences and digital healthcare.
Foster interdisciplinary collaborations and research partnerships.
Enhance your academic profile with publication opportunities in Scopus-indexed Taylor & Francis Conference Proceedings (subject to peer review and publisher policies).
Gain insights into emerging technologies shaping the future of healthcare.
Receive a certificate of participation and expand your professional network.
Conference Tracks
Five tracks covering the frontiers of pharmaceutical sciences and digital healthcare. Authors should submit their manuscripts to the track that best aligns with their research.
This track focuses on innovative approaches in drug discovery, pharmaceutical biotechnology, bioanalytical techniques, and advanced analytical methods. It also covers regulatory science, quality-by-design, validation, compliance, and emerging strategies for efficient development and approval of pharmaceutical products.
This track explores novel drug delivery platforms, advanced formulation technologies, nanotechnology, targeted and controlled drug delivery, and biopharmaceutics. It also highlights sustainable pharmaceutical manufacturing, green processes, process optimization, and environmentally responsible approaches to pharmaceutical development.
This track covers the development and scientific evaluation of herbal and natural products, including pharmacological efficacy, safety, toxicological assessment, and standardization. It also encompasses clinical pharmacy research, therapeutic interventions, pharmacotherapy, and the translation of evidence-based natural products into healthcare applications.
This track focuses on the application of data analytics, digital therapeutics and emerging technologies in pharmaceutical sciences and healthcare. It includes AI-driven drug discovery, personalized care, digital health platforms, predictive analytics and technology enabled healthcare innovation
This track addresses contemporary public health issues, disease prevention, healthcare accessibility, and emerging global health challenges. It also explores precision medicine, personalized therapeutics, population health, health disparities, and innovative strategies for building resilient and sustainable healthcare systems.
Important Steps to Follow
Authors are requested to carefully read and follow the instructions below for successful manuscript submission and conference registration.
Create a Microsoft CMT Account & Submit Your Manuscript
- Create an account on the Microsoft CMT Portal (if you do not already have one).
- Submit your full manuscript through the Microsoft CMT Portal before the submission deadline.
- Ensure your manuscript is prepared in accordance with the conference template (Taylor & Francis) and submission guidelines.
- All manuscripts must be submitted only through the Microsoft CMT Portal. Submissions via email will not be considered.
Peer Review
- All submitted manuscripts will undergo a peer review process.
- Authors will be notified of the review outcome through the registered email address.
Registration after Acceptance
- Only authors whose papers are accepted are required to complete the registration process.
- Pay the applicable registration fee using the prescribed payment mode.
- After successful payment, complete the online registration form and upload the payment receipt, wherever required.
- Registration will be considered complete only after successful fee payment and verification by the organizing committee.
Call for Papers & Submission Guidelines
Authors are invited to submit original, unpublished full papers across the conference tracks, ensuring strict adherence to the submission guidelines below. All submissions undergo a rigorous peer review.
Responsibilities of Authors
- Authors must submit original, unpublished research that is not under consideration elsewhere.
- All data, methods, and findings should be presented accurately, ethically, and transparently, without fabrication, falsification, or inappropriate manipulation.
- Authors are responsible for properly acknowledging all sources and ensuring their work is free from plagiarism.
- Any potential conflicts of interest must be disclosed at the time of submission.
- Simultaneous submission of the same manuscript to multiple conferences or journals is strictly prohibited.
Plagiarism Prevention
- All submitted manuscripts will undergo plagiarism screening to ensure academic integrity.
- Manuscripts exceeding the permissible similarity threshold may be returned for revision or clarification.
- Confirmed cases of plagiarism will result in immediate rejection and may lead to further action by the Conference Organizing Committee.
Submission Requirements
- Submit original, unpublished full-length manuscripts through Microsoft CMT.
- Abstract should be 150–200 words, along with 5–6 keywords.
- A maximum of five (5) authors is permitted per manuscript.
- Manuscripts should not exceed 5 pages (including references) or 3,000 words.
- Use Times New Roman, 10-point font, and single (1.0) line spacing.
- Manuscripts must be submitted in editable Microsoft Word (.doc/.docx) format named "Full Name ICPSDE_2026".
- Submissions must be original, properly cited, with a similarity index below 10%, and compliant with the conference AI usage policy.
- Only accepted and registered papers will be scheduled for presentation and considered for publication.
- Each accepted paper is entitled to one participation certificate. Additional individual certificates may be requested at a nominal fee.
- Authors must disclose any conflicts of interest during submission.
- Research involving human participants or experimental animals must have prior approval from the appropriate Institutional Ethics Committee (IEC) or Institutional Animal Ethics Committee (IAEC), where applicable.
- Authors should prepare manuscripts using the official Taylor & Francis Conference Paper Template, available on the conference website.
Register & Pay
Scan the QR code or use the link below to complete your conference registration and pay the registration fee securely.
You will be redirected to the secure conference registration portal.
| Formatting at a Glance | |
|---|---|
| Paper Type | Full-Length Research Paper |
| Submission Portal | Microsoft CMT |
| File Format | Microsoft Word (.doc/.docx) |
| Abstract | 150–200 words |
| Keywords | 5–6 |
| Maximum Authors | Up to 5 |
| Manuscript Length | Max 5 pages (incl. references) or 3,000 words |
| Font | Times New Roman, 10 pt |
| Line Spacing | Single (1.0) |
| Review Process | Peer Review |
| Similarity Index | Below 10% |
| AI Usage | Only as per the Conference AI Policy; authors remain responsible for originality and integrity. |
| Ethical Approval | IEC/IAEC approval required for studies involving humans or animals, where applicable |
| Conflicts of Interest | Mandatory disclosure during submission |
| Publication | Scopus-indexed Taylor & Francis Conference Proceedings (subject to peer review, editorial policies, and indexing criteria) |
| Certificate | One per accepted paper; additional on request |
Submission Process
- Authors are required to submit their full-length manuscripts.
- Authors must complete the conference registration through the official registration portal within the stipulated deadline.
- Participants who wish to attend the conference without presenting a paper may also register using the same registration portal.
- Following the conference presentation, authors are expected to revise their manuscripts by incorporating the comments and suggestions received from reviewers and session participants, wherever applicable.
- The revised camera-ready manuscripts will undergo a final editorial assessment to ensure compliance with the conference publication guidelines.
- Selected and accepted papers that successfully satisfy the peer-review process, editorial requirements, and publication quality standards will be considered for publication in the Taylor & Francis Conference Proceedings, subject to the publisher’s editorial policies and Scopus evaluation and indexing criteria.
- Authors must ensure that their submissions are original, unpublished, and free from plagiarism, and comply with the conference’s publication ethics and formatting guidelines.
- The decision of the Editorial Board and Technical Program Committee regarding paper acceptance and publication shall be final.
Publication Opportunity
Accepted and presented papers will be considered for publication in Scopus-indexed Taylor & Francis Conference Proceedings (subject to Scopus protocols and checks).
Submit Your Manuscript
Ethical Statement
The International Conference on Pharmaceutical Sciences in Digital Era (ICPSDE 2026) is committed to maintaining the highest standards of publication ethics, academic integrity, and transparency in accordance with the principles of the Ethical Committee. All submitted manuscripts must be original, unpublished, and not under consideration elsewhere.
Every submission will undergo plagiarism screening, AI-assisted content verification (where applicable), and a rigorous peer-review process to ensure fairness, confidentiality, and scholarly quality. Any form of research misconduct — including plagiarism, data fabrication, data falsification, duplicate submission, inappropriate authorship, or undisclosed conflicts of interest — will result in rejection of the manuscript and may lead to further action by the Conference Organizing Committee.
Authors are also required to submit a duly signed Consent Form confirming that they have obtained all necessary permissions for the use of any third-party content, including personal information, images, tables, figures, or other copyrighted material, wherever applicable.
Transparency Statement
These Proceedings are from Conference ICPSDE 2026 which is organised by School of Pharmacy at Noida International University.
The Editorial decision making and oversight of peer review is conducted by the Editorial decision makers Prof. (Dr.) Sameer Rastogi, Dean School of Pharmacy, Noida International University and Dr. Preeti Kush, Associate Professor, Adarsh Vijendra Institute of Pharmaceutical Sciences, Shobhit University, Noida, Uttar Pradesh including the Editorial and Review Board mentioned on the Website.
The Peer Review process is conducted by a committee of academicians who jointly assessed each article. The subject experts are chosen from a pool of Peer Reviewers to peer review the articles invited from the wide academic community. The External Review Committee along with Internal Review Committee is led by Dr. Raman Yadav, Assistant Professor, School of Pharmacy.
Taylor and Francis play no part in the choice of Editors or Peer Reviewers for these proceedings.
Responsibilities of the Editorial Board
- The editorial board is responsible for ensuring the integrity of the publication process. They should make decisions on submissions based solely on the academic merit of the work and its relevance to the conference's scope. The editorial board must ensure that the review process is conducted fairly, confidentially, and without bias.
- They are also responsible for identifying and addressing any ethical issues that may arise, such as suspected plagiarism, data manipulation, or conflicts of interest. The board is committed to maintaining transparency throughout the publication process and will take appropriate action in cases of malpractice, which may include rejecting manuscripts, issuing retractions, or reporting misconduct to the authors' institutions.
Responsibilities of Reviewers
- Evaluate manuscripts objectively based on scientific merit, originality, and relevance.
- Maintain confidentiality throughout the review process.
- Provide constructive, unbiased, and timely feedback.
- Declare any conflicts of interest and ensure impartiality.
- Identify relevant uncited literature and report ethical concerns, including plagiarism or research misconduct, to the Editorial Committee.
Registration Details
| Registration Category | Early Registration Till 10th October 2026 | Late Registration After 10th October 2026 |
|---|---|---|
| Foreign Author (For Presentation and Publication) | 150 USD | 175 USD |
| Industry Professionals (For Presentation and Publication) | Rs. 14,000/- | Rs. 15,000/- |
| Academicians and Faculty (For Presentation and Publication) | Rs. 12,000/- | Rs. 13,000/- |
| Research Scholars (For Presentation and Publication) | Rs. 10,000/- | Rs. 11,000/- |
| For attending the conference as Delegates | Rs. 700/- | Rs. 1,000/- |
| Note- All offline Presenters will be provided with lunch and kit. | ||
Note: Registration is mandatory for accepted papers.
Important Dates
Note: Paper submission, review management, and acceptance notifications will be handled through the official Microsoft CMT portal.
Conference Committee
Ethical Committee Members
The ‘Multidisciplinary Approach to Humanities and Social Sciences’ takes ethical misconduct seriously and has established procedures to address such issues. If unethical behavior is suspected, the editorial board will investigate the matter thoroughly. If misconduct is confirmed, appropriate actions will be taken, which may include the rejection of the manuscript, notify the authors’ institutions, and ban the authors from future participation in the conference. All investigations and actions will be conducted in accordance with the principles of fairness, confidentiality, and transparency.
Email: dean.sop@niu.edu.in
Email: preeti.kush@shobhituniversity.ac.in
Conference Sub-Committees
Coordination Committee
- Dr. Abhilasha Singh (Head)
- Dr. Nitin Kumar
- Ms. Nidhi Srivastava
- Ms. Sapna Joshi
- Mr. Ritik Saxena
- Mr. Shubh Deep Yadav
- Ms. Gunjan Nautiyal
Funding & Finance Committee
- Ms. Nidhi Srivastava (Head)
- Mr. Raju Singh
- Ms. Priti Tiwari
- Mr. Shubh Deep Yadav
Technical Committee
- Mr. Ritik Saxena (Head)
- Dr. Neha Raina
- Ms. Shivani Gupta
- Ms. Payal Chauhan
- Ms. Nisha Gupta
Registration Committee
- Ms. Priti Tiwari (Head)
- Mr. Kapil Bhardwaj
- Ms. Kumari Sonu
- Mr. Rajan Chauhan
- Mr. Shubh Deep Yadav
Plagiarism & AI Committee
- Dr. Raman Yadav (Head)
- Dr. Abhilasha Singh
- Dr. Mansi Dahalia
Hospitality & Logistics Committee
- Mr. Raju Singh (Head)
- Mr. Rajan Chauhan
- Mr. Chaitanay Vinayak Narayan
- Mr. Kapil Bhardwaj
Discipline Committee
- Dr. Nitin Kumar (Head)
- Mr. Kapil Bhardwaj
- Mr. Raju Singh
- Mr. Jagdeep
Certificate Committee
- Ms. Gunjan Nautiyal (Head)
- Ms. Priti Tiwari
- Mr. Rajan Chauhan
- Ms. Kumari Sonu
- Mr. Kapil Bhardwaj
Keynote Speakers
Editor
External Editor Board Members
- Dr. Anita Singh Professor, Pharmacy, MIET, Meerut
- Dr. Saumya Das Professor, Pharmacy, NIET, Greater Noida
- Dr. Shiv Kant Sharma Professor, Pharmacy, Gurugram University, Gurugram
- Dr. Lubhan Singh Professor, Pharmacy, Subharti University, Meerut
- Dr. Ram Babu Tripathi Professor, Pharmacy, Amity University, Gwalior
- Dr. Neelottama Kushwaha Professor, Krishana Institute of Pharmacy, Kanpur
- Dr. Pankaj Bhatt Associate Professor, Lloyd College of Pharmacy, Greater Noida
- Dr. Ankit Kumar Associate Professor, Pharmacy, ICFAI University, Dehradun
- Dr. Maksood Ali Professor, Orlean College of Pharmacy, Greater Noida
- Dr. Roma Ghai Professor, Pharmacy, KIET University, Ghaziabad
- Dr. Harpreet Singh Professor, School of Pharmacy, IFTM University
- Dr. Anupama Singh Professor, Pharmacy, SBS University, Dehradun
- Dr. Madhu Verma Professor, ITS College of Pharmacy, Ghaziabad
- Dr. Shrestha Sharma Associate Professor, Amity Institute of Pharmacy, Haryana
- Ms. Rekha Jethi Associate Professor, JBIT College of Pharmacy, Dehradun
- Dr. Esha Vats Associate Professor, Pharmacy, Jigyasa University, Dehradun
- Dr. Shashank Sony Professor, Pharmacy, Amity University, Lucknow
- Dr. Amrita Singh Assistant Professor, Pharmacy, CSJM University, Kanpur
- Mr. Ankit Tyagi Associate Professor, Maharishi University, Noida
Advisory Board Committee
- Dr. Akash VedDean Pharmacy, AKTU, Lucknow
- Dr. Rajiv Kumar TonkDSW, Department of Pharmaceutical Chemistry, SPS, DIPSRU, New Delhi
- Dr. Sayeed AhmadDirector, Head of Pharmacognosy, SPER, Jamia Hamdard, New Delhi
- Dr. Manas DasDirector, Orlean College of Pharmacy, Greater Noida
- Dr. Manjul Pratap SinghPrincipal Pharmacy, G S University, Hapur
- Dr. Nakul GuptaDirector, Pharmacy, IIMT College, Greater Noida
- Dr. Vandana Arora SethiDirector, Lloyd College of Pharmacy, Greater Noida
- Dr. Lalit TyagiPrincipal, Lloyd College of Pharmacy, Greater Noida
- Dr. Pallavi Manish LavhalePrincipal, Pharmacy, Rameesh Group of Institutions, Greater Noida
- Dr. S. Sadish KumarDirector, ITS College of Pharmacy, Ghaziabad
- Dr. Tarun VirmaniDean, Amity School of Pharmacy, Greater Noida
- Dr. Anurag VermaDean, School of Pharmacy, TMU, Moradabad, U.P.
- Dr. Sanjar AlamPrincipal Pharmacy, R.V. Northland, Dadri, Greater Noida
- Dr. Ganesh BhattPrincipal, Swami Rama Himalayan University, Dehradun
- Dr. Sayantan MukhopadhyayProfessor, Shivalik College of Pharmacy, Dehradun
- Dr. Vikas Anand SaharanProfessor, NIPER, Guwahati
- Dr. R.D. GuptaSunderdeep University, Ghaziabad
- Dr. Anuj MittalDirector, HIMT College of Pharmacy, Greater Noida
- Dr. Veerma RamDean, Pharmacy, SBS University, Dehradun
- Dr. Kamal ShahDean, Pharmacy, GLA University, Mathura
- Dr. Neelam SinghHOD, Pharmacy, HRIT University, Ghaziabad
- Dr. Monika SachdewaDirector, Pharmacy, RKGIT, Ghaziabad
- Dr. Amarjeet SinghDirector, Innovative College of Pharmacy, Greater Noida
- Dr. Ajit KiranAccurate College of Pharmacy, Greater Noida
- Dr. Mamta FarswanDean, Pharmacy, COER University, Roorkee
Contact Us
Noida International University
Plot No. 1, Sector-17A, Yamuna Expressway, (Opp. F1 Track),
Gautam Budh Nagar – 201312, Uttar Pradesh, India
Website: www.niu.edu.in
Email: icpsde2026@niu.edu.in
Contact Persons:
- Dr. Abhilasha Singh (Convener) – 7619878313
- Dr. Nitin Kumar (Co-Convener) – 8755033045
- Mr. Ritik Saxena (Organizing Secretary) – 7607676838